Inventor · disambiguated record
Kelly R. Bales
Also filed as: BALES KELLY · BALES KELLY R · BALES KELLY RENEE
8 granted patents·12 pending applications·226 citations·filing 1998–2023
87Inventor score
Top patents by PatentIndex Score
20 records- 0197US7195761B2Humanized antibodies that sequester abeta peptideUNIV WASHINGTON·Filed 2002·Granted Mar 27, 2007·185 cites·12 claims
- 0287US8591894B2Humanized antibodies that sequester amyloid beta peptideHOLTZMAN DAVID M·Filed 2010·Granted Nov 26, 2013·12 cites·18 claims
- 0384US7892545B2Humanized antibodies that sequester amyloid beta peptideLILLY CO ELI·Filed 2008·Granted Feb 22, 2011·5 cites·24 claims
- 0477US7771722B2Assay method for alzheimer's diseaseLILLY CO ELI·Filed 2002·Granted Aug 10, 2010·13 cites·28 claims
- 0559US2025295809A1Compositions and methods for the treatment of her2 positive cancerVOYAGER THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0659US2025049955A1Compositons and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0758US9453069B2Assay method for Alzheimer's diseaseLILLY CO ELI·Filed 2013·Granted Sep 27, 2016·0 cites·7 claims
- 0858US2025223376A1Compositions and methods for the treatment of her2 positive cancerVOYAGER THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0956US2022333133A1Vectorized editing of nucleic acids to correct overt mutationsVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1056US2023227802A1Compositions and methods for the treatment of neurological disorders related to glucosylceramidase beta deficiencyVOYAGER THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1155US2006039906A1Humanized antibodies that sequester abeta peptideHOLTZMAN DAVID M·Filed 2005·Application pending·0 cites
- 1251US8444977B2Assay method for Alzheimer's diseaseHOLTZMAN DAVID M·Filed 2010·Granted May 21, 2013·0 cites·12 claims
- 1350US2007036761A1Lentiviral apoe2 gene therapyBALES KELLY R·Filed 2004·Application pending·0 cites
- 1450US2024124889A1Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulationVOYAGER THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1549US6077852ATreatment of central nervous system disorders with selective estrogen receptor modulatorsLILLY CO ELI·Filed 1998·Granted Jun 20, 2000·8 cites·5 claims
- 1648US2004241164A1Use of antibodies having high affinity for soluble ab to treat conditions and diseases related to assFiled 2002·Application pending·0 cites
- 1747US2002013342A1Treatment of central nervous system disorders with selective estrogen receptor modulatorsFiled 2000·Application pending·0 cites
- 1845US2002155426A1Prevention and treatment of amyloid-associated disordersFiled 2002·Application pending·0 cites
- 1940US6428950B1Assay to identify compounds that alter apolipoprotein E expressionSCIOS INC·Filed 1999·Granted Aug 6, 2002·3 cites·2 claims
- 2038US2006073149A1Rapid improvement of cognition in condition related to abetaBALES KELLY R·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kelly R. Bales files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →